|LETTER TO THE EDITOR - OBSERVATION LETTER
|Year : 2018 | Volume
| Issue : 6 | Page : 712-717
Co-localization of immunobullous diseases at sites of dermatophytoses: Koebnerisation or a coincidence?
Amanjot Kaur Arora1, Dipankar De1, Uma Nahar Saikia2, Sanjeev Handa1
1 Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
2 Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
|Date of Web Publication||04-Oct-2018|
Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Sector-12, Chandigarh - 160 012
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Arora AK, De D, Saikia UN, Handa S. Co-localization of immunobullous diseases at sites of dermatophytoses: Koebnerisation or a coincidence?. Indian J Dermatol Venereol Leprol 2018;84:712-7
|How to cite this URL:|
Arora AK, De D, Saikia UN, Handa S. Co-localization of immunobullous diseases at sites of dermatophytoses: Koebnerisation or a coincidence?. Indian J Dermatol Venereol Leprol [serial online] 2018 [cited 2020 Jun 3];84:712-7. Available from: http://www.ijdvl.com/text.asp?2018/84/6/712/242768
Dermatophytic infections are commonly seen in patients with autoimmune bullous disorders due to iatrogenic immunosuppression. Occasionally, Koebner's phenomenon has been reported in patients with autoimmune bullous disorders. Herein we describe 6 interesting cases of autoimmune bullous disorders co-localizing with dermatophytoses and discuss if koebnerisation is the right term to define this phenomenon.
The index case was a 55-year-old male with pemphigus vulgaris. He had been treated with intravenous dexamethasone cyclophosphamide pulse therapy and was in remission for 6 months. Two weeks prior to reporting to us, he again developed vesiculobullous lesions overlying an erythematous, hyperpigmented, scaly plaque involving both the groin and pubic area [Figure 1]. Tzanck smear and potassium hydroxide mount from the lesions showed acantholytic cells and septate fungal hyphae, respectively. He was treated with oral terbinafine (250 mg once a day) and topical sertaconazole application with no relief over 3 weeks. A skin biopsy was taken for histopathological examination and direct immunofluorescence. Skin biopsy showed suprabasal split with acantholytic cells along with periodic acid Schiff positive fungal elements in the stratum corneum on the roof of the bulla [Figure 2]a and [Figure 2]b. Direct immunofluorescence showed intraepidermal deposits of IgG and C3 in a “fishnet pattern” [Figure 2]c. He was successfully treated with a combination of oral prednisolone 20 mg once a day, tapered over 3 months, and terbinafine 250 mg twice a day for 8 weeks. He was followed up for 6 months with no relapse. The clinical presentation and treatment details of all the six patients are tabulated in [Table 1] and skin lesions of the remaining patients are shown in [Figure 3]a, [Figure 3]b, [Figure 3]c, [Figure 3]d, [Figure 3]e. Histopathologic examination and direct immunofluorescence were consistent with the clinical diagnoses in all the cases and periodic acid Schiff positive fungal elements were observed either in the stratum corneum or in the bullous cavity [Figure 4]a, [Figure 4]b, [Figure 4]c, [Figure 4]d, [Figure 4]e, [Figure 4]f, [Figure 4]g.
|Figure 1: Index patient (case 1) with vesicular lesions localized on an erythematous and hyperpigmented plaque of dermatophytic infection on the medial aspect of both thighs|
Click here to view
|Table 1: Clinical details of the patients with co localization of immunobullous diseases and dermatophytoses|
Click here to view
A differential diagnosis of bullous dermatophytoses was kept in these cases. However, lack of response to antifungals alone which were given for 3 weeks prior to starting steroids and pathognomonic lesional direct immunofluorescence positivity ruled out bullous dermatophytoses. All the cases were treated with a combination of systemic steroids and oral and topical antifungals to which they responded successfully, suggesting that dermatophytoses initiated an aberrant immune response in these cases necessitating the addition of steroids to control blistering.
Pemphigus vulgaris and foliaceus have been reported to koebnerize at sites of surgical trauma, laser surgery, skin grafts, skin biopsies and chemical peels. Similarly, bullous pemphigoid has been known to koebnerize at sites of surgical trauma, for example humeral hemiarthroplasty, coronary artery bypass and saphenous vein harvest site, hernia site, open reduction–internal fixation, amputation and at the site of skin biopsy. However, it is pertinent to note that many case reports describing the occurrence of Koebner's phenomenon in autoimmune bullous disorders diverge from the classic description of Koebner's phenomenon. Either they did not have a preexisting dermatosis or there was subsequent development of autoimmune bullous disorders at non-traumatized sites. Similarly, in one of our cases, bullous lesions developed for the first time at the site of dermatophytoses without any preexisting autoimmune bullous disorders. In three cases, generalization of blistering to normal skin was seen. Thus, it is a matter of debate if this co-localization could be described as Koebner's phenomenon.
A similar case was reported by Hsiao and Chu in 1995 where a patient of bullous pemphigoid (in remission) developed a recurrence localized exclusively to the site of dermatophytic infection, which was controlled by hiking the dose of oral steroid and adding an oral antifungal. Importantly, bullous dermatophytoses should be ruled out in such cases by doing appropriate investigations.
Although the exact pathomechanisms responsible for such a co-localization remain to be elucidated, the following hypotheses can be suggested. First, during the penetration phase, multiple keratolytic proteases are secreted by dermatophytes. It is possible that these proteases expose some cryptic antigens (epitope spreading), subsequently, bringing about production and localization of newly synthesized antibodies against the new antigens at the site of fungal infection. This is particularly relevant to those cases who do not have a pre-existing autoimmune bullous disorders. Second, in patients with persistent or chronic dermatophytoses, high levels of Th2 cytokines, IgE and IgG4 are produced against fungal antigens, for example, trichophytin. Possibly, these circulating IgG4 antibodies cause blistering by virtue of molecular mimicry. Third, dermatophytes via their cell wall carbohydrate molecules (β-glucan) are known to increase the expression of toll-like receptors 2 and 4 in the epidermis which have also been proposed to be of pathogenic significance in pemphigus.,
Thus, co-localization of autoimmune bullous disorders with dermatophytoses seems to be more than a mere coincidence. More studies may help establish the exact pathogenesis of this unique co-localization, which may subsequently elaborate the pathogenesis of autoimmune bullous disorders itself.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form the patients have given their consent for their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Rotunda AM, Bhupathy AR, Dye R, Soriano TT. Pemphigus foliaceus masquerading as postoperative wound infection: Report of a case and review of the Koebner and related phenomenon following surgical procedures. Dermatol Surg 2005;31:226-31.
Hsiao GH, Chiu HC. Dermatophyte infection associated with a local recurrence of bullous pemphigoid. Br J Dermatol 1995;132:833-5.
Giordano CN, Sinha AA. Cytokine networks in pemphigus vulgaris: An integrated viewpoint. Autoimmunity 2012;45:427-39.
Sun XK, Chen JF, Shen H. Immunohistochemical study of toll-like receptors 2, 4, and 9 expressions in pemphigus and bullous pemphigoid lesions. Arch Dermatol Res 2016;308:429-36.
Brasch J, Morig A, Neumann B, Proksch E. Expression of antimicrobial peptides and toll-like receptors is increased in tinea and pityriasis versicolor. Mycoses 2014;57:147-52.
[Figure 1], [Figure 2], [Figure 3], [Figure 4]